Agronomed Pharmaceuticals is Pharmaceuticals in United States that focus on leverages technology business. Founded in 2017. They cover business area such as Provider, cannabis-base health product, medical purpose, effective formulation, biochemistry and bio-genetic, leverage technology, datum, patient outcome, people, access, advance, medical cannabis.
2017
( 7 years old in 2024 )
Leverages Technology
-
600 Eagleview Boulevard
Exton, PA 19341
United States
Private
Providercannabis-base health productmedical purposeeffective formulationbiochemistry and bio-geneticleverage technologydatumpatient outcomepeopleaccessadvancemedical cannabis
* We use standard office opening hours in near Agronomed Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Agronomed Pharmaceuticals is Pharmaceuticals business from United States that founded in 2017 (7 years old in 2024), Agronomed Pharmaceuticals business is focusing on Leverages Technology.
Agronomed Pharmaceuticals headquarter office and corporate office address is located in 600 Eagleview Boulevard Exton, PA 19341 United States.
Agronomed Pharmaceuticals was founded in United States.
In 2024, Agronomed Pharmaceuticals is currently focus on leverages technology sector.
Above is snippet of Google Trends for "leverages technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Agronomed Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
